Analytical will serve as a collection and distribution point for blood samples, DMA, original clinical pathology slides, and colorectal polyp tissue blocks. It will provide a resource and service for carrying out the laboratory analyses proposed in this application. We will develop appropriate sample collection, tracking, storage, and preparation procedures for all biologic samples collected during the course of this proposal. It will develop and optimize methods of measuring the laboratory research endpoints. Analytical will be responsible for the collection, logging, processing, distribution, and tracking of all tissues and samples. Endpoints to be analyzed include blood levels of the treatment drugs, celecoxib and selenium, and COX-2 expression in colorectal polyps. Analytical will oversee and coordinate the collection and processing of all samples related to this Program Project at the various participating hospitals and clinics Furthermore, we will be responsible for the training of personnel involved in the collection and processing of study samples. We will manage the pathology review of all polyp tissue included within this proposal. It will perform work closely with Biometry to provide data for reporting and interpretation. Quality assurance and quality control procedures will continue to be developed in collaboration with Biometry for sample acquisition, processing, and analysis procedures included in each of the clinical projects. Genotyping will support the genotyping needs. We will work with the leaders and co-leaders in testing the hypothesis that genetic polymorphisms (1) play a role in the response of individuals to celecoxib and/or selenium treatment and (2) confer increased susceptibility to advanced and/or recurrent colorectal adenomas and colorectal neoplasia. The goals will be achieved through the development and design of assays against both known functional polymorphisms and yet to be identified functional polymorphisms via haplotype analysis. We will efficiently track DMA samples, provide quality control and assurance, perform genetic analyses, and provide data management of the genotyping databases.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA041108-20
Application #
7310960
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
20
Fiscal Year
2006
Total Cost
$493,526
Indirect Cost
Name
University of Arizona
Department
Type
DUNS #
806345617
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Lance, Peter; Alberts, David S; Thompson, Patricia A et al. (2017) Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer Prevention. Cancer Prev Res (Phila) 10:45-54
Thompson, Patricia A; Ashbeck, Erin L; Roe, Denise J et al. (2016) Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes. J Natl Cancer Inst 108:
Jacobs, Elizabeth T; Haussler, Mark R; Alberts, David S et al. (2016) Association between Circulating Vitamin D Metabolites and Fecal Bile Acid Concentrations. Cancer Prev Res (Phila) 9:589-97
Liu, Lin; Messer, Karen; Baron, John A et al. (2016) A prognostic model for advanced colorectal neoplasia recurrence. Cancer Causes Control 27:1175-85
Thompson, Patricia A; Ashbeck, Erin L; Roe, Denise J et al. (2016) Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial. J Natl Cancer Inst 108:
Hibler, Elizabeth A; Sardo Molmenti, Christine L; Dai, Qi et al. (2016) Physical activity, sedentary behavior, and vitamin D metabolites. Bone 83:248-255
Minasian, Lori M; Tangen, Catherine M; Wickerham, D Lawrence (2015) Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program. Semin Oncol 42:748-63
Bea, Jennifer W; Jurutka, Peter W; Hibler, Elizabeth A et al. (2015) Concentrations of the vitamin D metabolite 1,25(OH)2D and odds of metabolic syndrome and its components. Metabolism 64:447-59
Hibler, Elizabeth A; Klimentidis, Yann C; Jurutka, Peter W et al. (2015) CYP24A1 and CYP27B1 Polymorphisms, Concentrations of Vitamin D Metabolites, and Odds of Colorectal Adenoma Recurrence. Nutr Cancer 67:1131-41
Molmenti, Christine L Sardo; Hibler, Elizabeth A; Ashbeck, Erin L et al. (2014) Sedentary behavior is associated with colorectal adenoma recurrence in men. Cancer Causes Control 25:1387-95

Showing the most recent 10 out of 149 publications